SCCM Resource Library-June Journal Club: Spotlight on Pharmacy (2024)

Video Transcription

Video Summary

Today's Journal Club Spotlight on Pharmacy webcast featured presentations on various research studies related to pharmacy practice in the intensive care unit setting. The first presentation by Lauren Schmidt focused on the efficacy and safety of Andexanet Alpha as a reversal agent for factor Xa inhibitors in patients with intracerebral hemorrhage. The study found that Andexanet demonstrated high hemostatic efficacy but was associated with an increased risk of thrombotic events compared to standard of care. The second presentation by Brett Snyder examined the use of nebulized ketamine versus intravenous subdissociative dose ketamine for acute pain in the emergency department. The study found that nebulized ketamine was a viable alternative to IV ketamine with no significant difference in pain reduction at 30 minutes. The third presentation by Madison Roberts discussed the impact of implementing computerized decision support alerts tailored to intensive care on the administration of high-risk drug combinations and their monitoring. The study showed a decrease in high-risk drug combinations administered and an increase in appropriate monitoring in the intervention group. Overall, these studies shed light on important considerations for improving patient care and safety in the critical care setting through the use of novel interventions and alert systems.

Asset Subtitle

Pharmacology, Neuroscience, 2024

Asset Caption

The Journal Club: Spotlight on Pharmacy webcast series focuses on pharmacy topics. This event is held on the third Friday of each month and features lively discussion and in-depth presentations on the latest research. Registered attendees receive complimentary access to the webcast for one year.

Meta Tag

Content Type Webcast

Knowledge Area Pharmacology

Knowledge Area Neuroscience

Membership Level Professional

Membership Level Select

Tag Analgesia and Sedation

Tag Intracranial Hemorrhage

Year 2024

Keywords

Pharmacy

Intensive Care Unit

Andexanet Alpha

Factor Xa Inhibitors

Intracerebral Hemorrhage

Nebulized Ketamine

Intravenous Ketamine

Computerized Decision Support

High-Risk Drug Combinations

Patient Safety

Webcast

Pharmacology

Neuroscience

Analgesia and Sedation

Intracranial Hemorrhage

2024

Professional

Select

	Society of Critical Care Medicine 500 Midway Drive Mount Prospect, IL 60056 USA Phone: +1 847 827-6888 Fax: +1 847 439-7226 Email: support@sccm.org	Contact Us About SCCM Newsroom Advertising & Sponsorship DONATE	MySCCM LearnICU Patients & Families Surviving Sepsis Campaign Critical Care Societies Collaborative	GET OUR NEWSLETTER
© Society of Critical Care Medicine. All rights reserved. \| Privacy Statement \| Terms & Conditions The Society of Critical Care Medicine, SCCM, and Critical Care Congress are registered trademarks of the Society of Critical Care Medicine.